But at least, our data indicate that lupus patients would be better to reduce salt in-take and the underlying mechanism might provide new therapeutic target for SLE, with interference TET2 and spn to attenuate pathogenic Tfh cells. The gene discussed is SPN; the disease is systemic lupus erythematosus.